Literature DB >> 22704506

Expanding the boundaries of embryonic stem cells.

Uri Ben-David1, Oded Kopper1, Nissim Benvenisty2.   

Abstract

The boundaries of embryonic stem cell (ESC) research have extended considerably in recent years in several important ways. Alongside a deeper understanding of the pluripotent state, ESCs have been successfully integrated into various fields, such as genomics, epigenetics, and disease modeling. Significant progress in cell fate control has pushed directed differentiation and tissue engineering further than ever before and promoted clinical trials. The geographical distribution of research activity has also expanded, especially for human ESCs. This review outlines these developments and future challenges that remain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22704506     DOI： 10.1016/j.stem.2012.05.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  28 in total

1.  rsPSCs: A new type of pluripotent stem cells.

Authors:  Uri Weissbein; Nissim Benvenisty
Journal:  Cell Res       Date:  2015-06-16       Impact factor: 25.617

2.  Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium.

Authors:  David E Buchholz; Britney O Pennington; Roxanne H Croze; Cassidy R Hinman; Peter J Coffey; Dennis O Clegg
Journal:  Stem Cells Transl Med       Date:  2013-04-18       Impact factor: 6.940

Review 3.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

4.  Chemical ablation of tumor-initiating human pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

Review 5.  Aneuploidy in stem cells.

Authors:  Jorge Garcia-Martinez; Bjorn Bakker; Klaske M Schukken; Judith E Simon; Floris Foijer
Journal:  World J Stem Cells       Date:  2016-06-26       Impact factor: 5.326

6.  Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells.

Authors:  Kyle R Denton; Chongchong Xu; Harsh Shah; Xue-Jun Li
Journal:  Front Biol (Beijing)       Date:  2016-09-28

Review 7.  Induced pluripotent stem cell technology: a decade of progress.

Authors:  Yanhong Shi; Haruhisa Inoue; Joseph C Wu; Shinya Yamanaka
Journal:  Nat Rev Drug Discov       Date:  2016-12-16       Impact factor: 84.694

Review 8.  Ethical Issues for Clinical Studies That use Human Embryonic Stem Cells: The 2014 Revisions to the Japanese Guidelines.

Authors:  Hiroshi Mizuno
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

Review 9.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

Review 10.  Pluripotent stem cells and gene therapy.

Authors:  Pavel Simara; Jason A Motl; Dan S Kaufman
Journal:  Transl Res       Date:  2013-01-23       Impact factor: 7.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.